Guardant Reveal aids organ preservation in rectal cancer treatment
PALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ: NASDAQ:GH), a precision oncology company with a market capitalization of $5.8 billion, has presented new data at the American Society of Clinical ...
JD Supra26d
FDA and OHRP Issue Draft Guidance on Including Biopsies in Clinical Trials
The draft guidance notes as an example that a single muscle biopsy is often considered a procedure that does not exceed a minor increase over minimal risk. By contrast, a large internal organ ...